The unique viscoelastic biopolymer at the heart of our flagship products
TRB Chemedica has pioneered the use of sodium hyaluronate obtained by biofermentation, with a focus on patient safety and improved clinical outcomes.
Due to its high biocompatibility and common presence in the extracellular matrix of tissues, hyaluronic acid has gained popularity during recent decades and is now used in many fields of medicine, such as orthopaedics, rheumatology, ophthalmology, tissue repair, dermatology and surgery.1
TRB Chemedica and its talented employees continually strive to advance the cause of good health by developing treatments that improve symptoms and treat diseases. For more than 35 years, we have focused on improving patients’ quality of life through the delivery of high quality medicines.